Current with legislation from the 2023 Regular and Special Sessions signed by the Governor as of November 21, 2023.
Section 1003.060 - Construction of Subchapter This subchapter may not be construed to:
(1) prohibit a physician from using adult stem cells for their intended homologous use if the stem cells are: (A) produced by a manufacturer registered by the United States Food and Drug Administration; and(B) commercially available; or(2) require an institutional review board to oversee treatment using adult stem cells registered by the United States Food and Drug Administration for their intended homologous use.Tex. Health and Safety Code § 1003.060
Added by Acts 2019, Texas Acts of the 86th Leg.- Regular Session, ch. 1158,Sec. 5, eff. 9/1/2019.